Anti-HER2 CAR-T
TMMU-BTC-005
Phase 2 mab terminated
Quick answer
Anti-HER2 CAR-T for Breast Cancer is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Breast Cancer
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated